Selling a veterinary practice or group in the UK

You own a UK veterinary practice or group worth between £5M and £50M in enterprise value. A single-site small animal practice at the upper end of the segment. A regional first-opinion group of three to fifteen sites. A mixed or equine practice with strong client base depth. A specialist referral practice in oncology, orthopaedics, neurology or dermatology.

The buyer pool in UK vet M&A has evolved materially over the last 18 months. Several large PE-backed and corporate consolidators remain actively acquiring, but the CMA market investigation has changed both the pace and the diligence intensity. We track this carefully and advise owners on how it affects timing, buyer composition and process design. Specialist referral practices attract a separate, narrower but well-funded buyer pool again — including specialist referral consolidators and overseas strategics.

We engage 12 to 24 months before a target exit. In vet specifically, the regulatory environment under the CMA review and the importance of vet retention make the longer preparation window more material than ever. Practices that go to market without addressing vet retention and CMA-driven diligence expectations consistently underperform.

This is not the right fit if your practice is below £5M EV, or if vet retention is in active flux. In both cases we will be straight about why. It is also not the right fit if you are committed to a specific approach already on the table; that is execution support, which fits a different mandate.

Buyer diligence in UK veterinary M&A focuses on five items. Each has become sharper under the CMA review environment.

Vet retention first. The headline diligence concern across every buyer in this sector. Tenure data, salary benchmarks against the regional market, restrictive covenants, billings per vet, and any post-sale lock-in arrangements all sit at the top of the buyer pack. With the CMA review highlighting workforce dynamics, this has tightened further. Practices where senior vets have not been engaged with the transaction story consistently re-trade at completion.

Site economics second. Per-site EBITDA, revenue per FTE vet, client retention, average spend per client, and the proportion of revenue from preventive care plans. Multi-site groups where individual site performance varies widely are valued on the weaker sites.

Client base depth third. Active client count, client tenure distribution, revenue per client, and the proportion of revenue on subscription / health plans. A strong subscription book materially supports premium pricing because of revenue visibility.

Specialist accreditation fourth. RCVS practice standards accreditation level, specialist clinical accreditations, advanced practitioner status of senior team. These act as barriers to entry and support premium multiples, especially for specialist referral practices.

CMA-related diligence fifth. The CMA market investigation has introduced new diligence threads — pricing transparency, client communication standards, ownership disclosure, choice and switching. Buyers expect to see practices operating to the standards the CMA is establishing rather than the standards a previous regulatory environment tolerated. Practices that align ahead of time outperform.

Our six-stage process runs senior-led from first conversation to completion. For UK vet practices, three things shape execution in the current environment.

CMA-related diligence sits on a longer clock and a wider scope than vet practices have historically run. We design the process around this rather than discovering the implications late. Where pricing transparency, ownership disclosure or client communication standards need attention, the readiness phase is the right time to address them.

Vet engagement is structured into the process design from the start. We work with owners on how and when senior vets are told about the transaction, the post-sale lock-in arrangements, and any equity or retention arrangements that need to be in place. The single fastest way to lose a veterinary deal at completion is to fail to engage the team properly in advance.

Buyer mapping is segmented and changing fast. Active consolidators differ in CMA-readiness, size appetite, geographic preference, and integration intensity. Specialist referral practices attract an additional, narrower buyer pool again. Our buyer mapping is supported by our proprietary technology layer for surfacing acquirer signals from licensed market data. See the healthcare services pillar for context and dental practices for the closest adjacent niche.